Jorveza^® is an orodispersible tablet containing the topically acting corticosteroid budesonide. The formulation has been specifically developed for the targeted treatment of Eosinophilic Oesophagitis (EoE) and is the first and only oral steroid currently licensed in the UK and globally for this condition.
 

For further information, the Summary of Product Characteristics (SmPC) is available below.

Jorveza® 0.5mg orodispersible tablet
Jorveza® 1mg orodispersible tablet